Back

CCM efficacy in ATTR cardiomyopathy with mr to r EF and nyha III orIV

14 April 2026 (08:00 - 14:45)
Organised by: Logo
Congress Presentation Part of: Poster session (3): mechanisms and management of arrhythmias Clinical EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Procolo Marchese

EP lab, AST Ascoli Piceno, Ascoli Piceno (Italy)

188 More presentations in this session

Presentation thumbnail
Comparison of ECG findings between young patients with cryptogenic ischemic stroke and stroke-free control subjects
Doctor J. Uutela (Jyvaskyla, FI)
Abstract
Presentation thumbnail
A wearable SCG-based approach for early, low-cost screening of valvular heart disease
Doctor V. Pergola (Naples, IT)
Presentation thumbnail
Intraoperative assessment of cardiac parasympathetic tone using short-term HRV metrics before and after atropine administration: a pilot study
Doctor B. Hrymniak (Wroclaw, PL)
Abstract
Presentation thumbnail
Arrhythmia phenotypes in hair-loss therapies: insights from minoxidil and finasteride reports in eudravigilance
Doctor Y. Shhab (Bucharest, RO)
Abstract
Presentation thumbnail
Arrhythmias and device therapy in HFpEF: Insights from a real-world hospital cohort
Ms A. Bondoc (Timisoara, RO)
Abstract Slides Video

Access the full session

Session thumbnail
Poster session (3): mechanisms and management of arrhythmias

The Event

Event poster

EHRA 2026

14 April 2026 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Clinical implications of cardiac implantable electronic devices in ATTR cardiomyopathy
thumbnail
Congress Presentation
Cardiac resynchronization therapy, remodeling and outcome in patients with amyloid transthyretin cardiomyopathy
thumbnail
Congress Presentation
Amyloid cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources